Searched for
LAURUS LABS RESULTS
Laurus Labs, Biocon, Ather Energy, Lenskart among probable MSCI India Standard Index inclusion candidates, says JM FinancialJM Financial anticipates significant shifts in the MSCI India Standard Index. Laurus Labs and Biocon are flagged as high-probability additi...- Ahead of Market: 10 things that will decide D-Street action on MondayIndian benchmark indices ended marginally lower on Friday as investors assessed the RBI’s decision to keep rates unchanged while raising in...
- Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...
- Laurus Labs adds Rs 40,150 crore to investors' wealth in a year with 120% rally. Buy, hold or book profits?Laurus Labs has significantly boosted investor wealth, adding over Rs 40,000 crore in a year with a 120% stock rally. Driven by business im...
- Smallcaps & midcaps rally! Firstsource Solutions, Nuvama, Godfrey Phillips, other stocks jump up to 16%Smallcap and midcap stocks outperformed benchmarks on Friday, with select names rallying up to 16% despite broader market weakness. Gains w...
- Laurus Labs Q4 Results: Cons PAT increased 19% to Rs 279 crore, revenue rises 5%Laurus Labs reported a 19% year-on-year jump in net profit to Rs 279 crore for the March quarter, with revenue rising 5% to Rs 1,812 crore....
- Laurus Labs shares tumble 4% despite 886% surge in Q2 PAT. Should you buy the dip?Laurus Labs shares fell despite Q2FY26 PAT surging 886% to Rs 195 crore, revenue rising 35%, and EBITDA more than doubling, with margins ex...
- Laurus Labs Q4 Results: Profit soars 3-fold to Rs 234 crore; revenue at Rs 1,440 croreDrug firm Laurus Labs on Thursday said its consolidated profit increased three-fold to Rs 234 crore for the March quarter, driven by strong...
- Laurus Labs shares nosedive 15% amid reports of US foreign aid suspensionLaurus Labs reported a 7% YoY drop in API revenues to Rs 531 crore for Q3 FY24, driven by lower ARV volumes. However, the FDF segment saw A...
- Laurus Labs shares crash 10% after missing Q3 estimatesIn Q3, the company's revenue dropped 23% year-on-year (YoY) at Rs 1,195 crore while profit also dropped 89% YoY to Rs 23 crore.
- Laurus Labs shares hit 10% lower circuit on week Q2 earningsThe pharma company reported a consolidated net profit of Rs 37 crore, which was down by Rs 84% year-on-year versus Rs 233.39 crore posted b...
- Laurus Labs Q2 Results: Net profit nosedives 84% YoY to Rs 37 croreLaurus Labs' revenue for the quarter ended September declined 22.3% YoY to Rs 1,224 crore in Q2FY24. The company's earnings before interest...
- Q1 Results Today: Laurus Labs, IEX and ACCLaurus Labs Q1 consolidated net profit fell 90% YoY to INR25 crore due to lower sales and elevated expenses. The API business reported a 2%...
- Laurus Labs Q3 Results: Net profit rises 32% to Rs 203 croreDr. Satyanarayana Chava, founder and chief executive officer of Laurus Labs said the company is on path of diversification and strengthenin...
- Laurus Labs Q3 Results: PAT rises 32% YoY to Rs 203 cr, revenue jumps 50%Laurus Labs said revenue from its Synthesis and active pharmaceutical ingredients (API) businesses, each of which account for more than 40%...
- Laurus Labs net profit rises 15% to Rs 233 crore in Q2FY23The company had reported a net profit of Rs 202 crore during the same period of the previous year. On a quarter-on-quarter (QoQ) basis , th...
- Laurus Labs posts Rs 251 crore net profit in Q1FY23The company attributed this to the change in the effective tax rate for Q1FY23 on account of a drop in SEZ profits exemption u/s 10AA to 50...
- ET Emerging Company of the Year 2021: Laurus Labs-A pharma company beats the virus trap to make it bigIt supplies active pharmaceutical ingredients (APIs) to nine out of the 10 largest generic pharma companies and has leadership positions in...
- Laurus Labs Q3 results: Net profit drops 44% YoY to Rs 154 croreThe earnings before interest, tax, depreciation and amortization (EBITDA) decreased 17% YoY to Rs 290 crore. The EBITDA margins dropped by ...
- Laurus Labs Q3 results: Net profit zooms nearly 4-fold to Rs 273 crThe company had posted a net profit of Rs 73.47 crore for the corresponding period of the previous fiscal, Laurus Labs said in a filing to ...
Load More
